Hepatology Communications · 2022 · 11 citations · 27 references
MedicineOncologyRadiologyCancer ScreeningDiagnostic ImagingDiagnostic RadiologyCancer DetectionComputed TomographyComputer-aided DiagnosisLiver ImagingMedical ImagingTumor DetectionComputer-aided DetectionComputer-aided Tumor DiagnosisContrast-enhanced Computed TomographyHepatic Tumor ImagingHepatocellular Carcinoma ImagingLiver Lesion DetectionLiver Tumor ImagingVolumetric Estimation
Hepatocellular carcinoma (HCC) can be potentially discovered from abdominal computed tomography (CT) studies under varied clinical scenarios (e.g., fully dynamic contrast-enhanced [DCE] studies, noncontrast [NC] plus venous phase [VP] abdominal studies, or NC-only studies). Each scenario presents its own clinical challenges that could benefit from computer-aided detection (CADe) tools. We investigate whether a single CADe model can be made flexible enough to handle different contrast protocols and whether this flexibility imparts performance gains. We developed a flexible three-dimensional deep algorithm, called heterophase volumetric detection (HPVD), that can accept any combination of contrast-phase inputs with adjustable sensitivity depending on the clinical purpose. We trained HPVD on 771 DCE CT scans to detect HCCs and evaluated it on 164 positives and 206 controls. We compared performance against six clinical readers, including two radiologists, two hepatopancreaticobiliary surgeons, and two hepatologists. The area under the curve of the localization receiver operating characteristic for NC-only, NC plus VP, and full DCE CT yielded 0.71 (95% confidence interval [CI], 0.64-0.77), 0.81 (95% CI, 0.75-0.87), and 0.89 (95% CI, 0.84-0.93), respectively. At a high-sensitivity operating point of 80% on DCE CT, HPVD achieved 97% specificity, which is comparable to measured physician performance. We also demonstrated performance improvements over more typical and less flexible nonheterophase detectors. Conclusion: A single deep-learning algorithm can be effectively applied to diverse HCC detection clinical scenarios, indicating that HPVD could serve as a useful clinical aid for at-risk and opportunistic HCC surveillance.
27
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach, Laura Kulik, Richard S. Finn et al. · Hepatology · 2017 · 4.2K citations · Full text
Medicine, Oncology, Pharmacotherapy +12
Top-Down Neural Attention by Excitation Backprop
Jianming Zhang, Sarah Adel Bargal, Zhe Lin et al. · International Journal of Computer Vision · 2017 · 702 citations
Emerging trends in hepatocellular carcinoma incidence and mortality
Basile Njei, Yaron Rotman, Ivo Ditah et al. · Hepatology · 2014 · 559 citations